mating type switching donor selection

Known as: donor selection 
The process that determines which donor locus a cell uses, in preference to another, in mating type switching. [GOC:mah, PMID:9928492]
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Life-threatening graft-versus-host disease (GVHD) limits the use of HLA-C-mismatched unrelated donors in transplantation… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Killer-cell immunoglobulin-like receptor (KIR) genes form a diverse, immunogenetic system. Group A and B KIR haplotypes have… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Blood transfusion is an important mode of transmission of infections to recipients. The aim of the study was to assess the… (More)
Is this relevant?
2008
2008
Stem cell transplantation across HLA barriers may trigger NK cell-mediated graft-vs-leukemia effects leading to improved survival… (More)
Is this relevant?
2006
2006
INTRODUCTION The main limitation factor for wide use of umbilical cord blood units (UCBs) as a source of hematopoietic… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE Optimizing cord blood donor selection based mainly on cell dose and human leukocyte antigen (HLA) disparities may… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Context Current upper limits (500 nkat/L [30 U/L] for women, 667 nkat/L [40 U/L] for men) for serum alanine aminotransferase (ALT… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2002
2002
Human leukocyte antigen (HLA) incompatibilities are the most important immunological barriers to bone marrow transplant success… (More)
Is this relevant?
1998
1998
In comparison with HLA-matched sibling bone marrow transplants, unrelated donor transplants are associated with increased graft… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
1997
Review
1997
Bone marrow transplantation (BMT) is the present treatment for hematological malignancies. Two major drawbacks of allogeneic BMT… (More)
  • figure 1
  • table 3
  • table 4
  • table 4
  • table 5
Is this relevant?